EMPAGLIFLOZIN

Clinical Indication

Chronic heart failure with reduced ejection fraction.

Comments

In line with NICE TA773

Date of classification

May 2022

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .